Experiments will be carried out to study the processes whereby neurofilaments (NF) are degraded by calcium-activated neutral protease (CANP), the nature of the NF products which are generated by this fragmentation, the fate of the NF degradative products and, especially, the possibility that NF degradative products are transported retrogradely to the perikaryon and have regulatory (""""""""feedback"""""""") effects on the transcription, translation and/or assembly (i.e., turnover) of NF proteins. The enzymatic reaction between NF and CANP will be reconstituted from purified components and compared with the same reaction occurring in situ. Attention will be directed at how this reaction is modified by different forms of CANP, by the presence of endogenous inhibitor to the enzyme and when the substrate is present as insoluble """"""""filamentous"""""""" vs soluble """"""""protofilamentous"""""""" forms. Immunohistochemical methods will be used to compare the tissue distributions of CANP and CANP-Inhibitor with that of NF proteins. Monoclonal antibodies will be employed to probe the different forms of enzyme and enzyme inhibitor. The phenomena of NF degradation and turnover will be analyzed in pulse-labeled dissociated neuronal cultures. A model system of cell-free protein synthesis will be established in order to study translation of NF proteins, CANP and CANP-Inhibitor, the characteristics of the nascent proteins and factor (e.g., nucleotide-binding fragments of NF degradation) which may modify the translation of cytoskeletal proteins. The proposed studies will probe fundamental phenomena which regulate cell size and shape, thereby serving to establish and maintain neuronal connectivity and provide for the functional integrity of neural tissues. Furthermore, NF turnover may well underlie the capability of the neuron to respond to impairment by intrinsic or extrinsic factors of injurious or diseased states. Understanding the mechanisms which regulate NF turnover may allow the effects of neuronal impairment to be minimized or the regeneration and restoration of neuronal function to be optimezed.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS015722-10
Application #
3396446
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Project Start
1979-02-01
Project End
1992-05-31
Budget Start
1987-06-01
Budget End
1988-05-31
Support Year
10
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Lin, Hong; Zhai, Jinbin; Canete-Soler, Rafaela et al. (2004) 3' untranslated region in a light neurofilament (NF-L) mRNA triggers aggregation of NF-L and mutant superoxide dismutase 1 proteins in neuronal cells. J Neurosci 24:2716-26
Wu, Junhua; Zhai, Jinbin; Lin, Hong et al. (2003) Cytoplasmic retention sites in p190RhoGEF confer anti-apoptotic activity to an EGFP-tagged protein. Brain Res Mol Brain Res 117:27-38
Zhai, Jinbin; Lin, Hong; Nie, Zhenying et al. (2003) Direct interaction of focal adhesion kinase with p190RhoGEF. J Biol Chem 278:24865-73
Canete-Soler, R; Wu, J; Zhai, J et al. (2001) p190RhoGEF Binds to a destabilizing element in the 3' untranslated region of light neurofilament subunit mRNA and alters the stability of the transcript. J Biol Chem 276:32046-50
Canete-Soler, R; Schlaepfer, W W (2000) Similar poly(C)-sensitive RNA-binding complexes regulate the stability of the heavy and light neurofilament mRNAs. Brain Res 867:265-79
Canete-Soler, R; Silberg, D G; Gershon, M D et al. (1999) Mutation in neurofilament transgene implicates RNA processing in the pathogenesis of neurodegenerative disease. J Neurosci 19:1273-83
Schwartz, M L; Hua, Y; Canete-Soler, R et al. (1998) Characterization of the mouse neurofilament light (NF-L) gene promoter by in vitro transcription. Brain Res Mol Brain Res 57:21-30
Schwartz, M L; Hua, Y; Schlaepfer, W W (1997) In vitro activation of the mouse mid-sized neurofilament gene by an NF-1-like transcription factor. Brain Res Mol Brain Res 48:305-14
Schwartz, M L; Bruce, J; Shneidman, P S et al. (1995) Deletion of 3'-untranslated region alters the level of mRNA expression of a neurofilament light subunit transgene. J Biol Chem 270:26364-9
Schwartz, M L; Shneidman, P S; Bruce, J et al. (1994) Stabilization of neurofilament transcripts during postnatal development. Brain Res Mol Brain Res 27:215-20

Showing the most recent 10 out of 29 publications